4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-050074
Director sold 8,000 shares at $18.53 ($148,240)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-09-08 | Option exercise | +8,000 | $9.24 | $73,920 | 284,973 | D: show line 1 in the form |
| CHESS ROBERT Director | 2020-09-08 | Sale | −8,000 | $18.53 | $148,240 | 276,973 | D: show line 2 in the form |
| Open-market sales · 8,000 sh · avg $18.53 · $148,240 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-09-08 | Option exercise · Stock Option | −8,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…